HER-2-targeted nanoparticle-affibody bioconjugates for cancer therapy

Frank Alexis; Pamela Basto; Etgar Levy-Nissenbaum; Aleksandar F. Radovic-Moreno; Liangfang Zhang; Eric Pridgen; Andrew Z. Wang; Shawn L. Marein; Katrina Westerhof; Linda K. Molnar; Omid C. Farokhzad

doi:10.1002/cmdc.200800122

HER-2-targeted nanoparticle-affibody bioconjugates for cancer therapy

Frank Alexis, Pamela Basto, Etgar Levy-Nissenbaum, Aleksandar F. Radovic-Moreno, Liangfang Zhang, Eric Pridgen, Andrew Z. Wang, Shawn L. Marein, Katrina Westerhof, Linda K. Molnar, Omid C. Farokhzad

Producción científica: Contribución a una revista › Artículo › revisión exhaustiva

144 Citas (Scopus)

Resumen

(Figure Presented) Affibodies are a class of polypeptide ligand that are potential candidates for tissue-specific targeting of drug-encapsulated controlled release polymeric nanoparticles (NPs). We developed drug delivery vehicles composed of polymeric NPs surface modified with affibody ligands that bind the extracellular domain of the human epidermal growth factor receptor 2 (HER-2) for targeted delivery to cells that overexpress the HER-2 antigen.

Idioma original	Inglés
Páginas (desde-hasta)	1839-1843
Número de páginas	5
Publicación	ChemMedChem
Volumen	3
N.º	12
DOI	https://doi.org/10.1002/cmdc.200800122
Estado	Publicada - 15 dic. 2008
Publicado de forma externa	Sí

ODS de las Naciones Unidas

Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

Acceder al documento

10.1002/cmdc.200800122

Otros archivos y enlaces

Enlace a la publicación en Scopus

Citar esto

@article{781193df4e604e6a963dad31ed198a40,

title = "HER-2-targeted nanoparticle-affibody bioconjugates for cancer therapy",

abstract = "(Figure Presented) Affibodies are a class of polypeptide ligand that are potential candidates for tissue-specific targeting of drug-encapsulated controlled release polymeric nanoparticles (NPs). We developed drug delivery vehicles composed of polymeric NPs surface modified with affibody ligands that bind the extracellular domain of the human epidermal growth factor receptor 2 (HER-2) for targeted delivery to cells that overexpress the HER-2 antigen.",

keywords = "Affibodies, Antitumor agents, Nanoparticles, PLA-PEG copolymers, Targeted therapy",

author = "Frank Alexis and Pamela Basto and Etgar Levy-Nissenbaum and Radovic-Moreno, {Aleksandar F.} and Liangfang Zhang and Eric Pridgen and Wang, {Andrew Z.} and Marein, {Shawn L.} and Katrina Westerhof and Molnar, {Linda K.} and Farokhzad, {Omid C.}",

year = "2008",

month = dec,

day = "15",

doi = "10.1002/cmdc.200800122",

language = "Ingl{\'e}s",

volume = "3",

pages = "1839--1843",

journal = "ChemMedChem",

issn = "1860-7179",

number = "12",

}

TY - JOUR

T1 - HER-2-targeted nanoparticle-affibody bioconjugates for cancer therapy

AU - Alexis, Frank

AU - Basto, Pamela

AU - Levy-Nissenbaum, Etgar

AU - Radovic-Moreno, Aleksandar F.

AU - Zhang, Liangfang

AU - Pridgen, Eric

AU - Wang, Andrew Z.

AU - Marein, Shawn L.

AU - Westerhof, Katrina

AU - Molnar, Linda K.

AU - Farokhzad, Omid C.

PY - 2008/12/15

Y1 - 2008/12/15

N2 - (Figure Presented) Affibodies are a class of polypeptide ligand that are potential candidates for tissue-specific targeting of drug-encapsulated controlled release polymeric nanoparticles (NPs). We developed drug delivery vehicles composed of polymeric NPs surface modified with affibody ligands that bind the extracellular domain of the human epidermal growth factor receptor 2 (HER-2) for targeted delivery to cells that overexpress the HER-2 antigen.

AB - (Figure Presented) Affibodies are a class of polypeptide ligand that are potential candidates for tissue-specific targeting of drug-encapsulated controlled release polymeric nanoparticles (NPs). We developed drug delivery vehicles composed of polymeric NPs surface modified with affibody ligands that bind the extracellular domain of the human epidermal growth factor receptor 2 (HER-2) for targeted delivery to cells that overexpress the HER-2 antigen.

KW - Affibodies

KW - Antitumor agents

KW - Nanoparticles

KW - PLA-PEG copolymers

KW - Targeted therapy

UR - http://www.scopus.com/inward/record.url?scp=57549090074&partnerID=8YFLogxK

U2 - 10.1002/cmdc.200800122

DO - 10.1002/cmdc.200800122

M3 - Artículo

C2 - 19012296

AN - SCOPUS:57549090074

SN - 1860-7179

VL - 3

SP - 1839

EP - 1843

JO - ChemMedChem

JF - ChemMedChem

IS - 12

ER -

HER-2-targeted nanoparticle-affibody bioconjugates for cancer therapy

Resumen

ODS de las Naciones Unidas

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto